You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

amegakaryocytic thrombocytopenia

Showing 76 - 100 of 646
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Immune Thrombocytopenia Trial in Shandong (QL0911, Placebo comparator)

Completed
  • Primary Immune Thrombocytopenia
  • Shandong, China
    Qilu Hospital of Shandong University
Nov 20, 2022

Thrombocytopenia Trial in Hefei (Avatrombopag)

Completed
  • Thrombocytopenia
  • Hefei, Anhui, China
    Anhui Provincial Cancer Hospital
Apr 24, 2022

Tumor Therapy-related Thrombocytopenia Trial (TPO-RA (Herombopag), TPO-RA (Herombopag) and rhTPO(Recombinant human

Not yet recruiting
  • Tumor Therapy-related Thrombocytopenia
  • TPO-RA (Herombopag)
  • TPO-RA (Herombopag) and rhTPO(Recombinant human thrombopoietin)
  • (no location specified)
Apr 27, 2022

Immune Thrombocytopenia Trial in Beijing (TAC, Danazol)

Recruiting
  • Immune Thrombocytopenia
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Jul 20, 2022

TTP Patients: Italian Experience (ROSCAPLI)

Recruiting
  • Thrombotic Thrombocytopenic Purpura
  • Roma, Italy
    FPG
Mar 14, 2023

Thrombocytopenia Trial in New Delhi (Carica Papaya Leaf Extract, Placebo)

Recruiting
  • Thrombocytopenia
  • Carica Papaya Leaf Extract
  • Placebo
  • New Delhi, Delhi, India
    Institute of Liver & Biliary Sciences
Apr 30, 2022

Thrombocytopenia Trial in France (Eltrombopag)

Recruiting
  • Thrombocytopenia
  • Angers, France
  • +24 more
Jan 2, 2023

Immune Thrombocytopenia Trial (Terbutaline, Danazol)

Not yet recruiting
  • Immune Thrombocytopenia
  • (no location specified)
Aug 6, 2022

Thrombocytopenia Trial in China (Hydroxychloroquine, Cyclophosphamide, Azathioprine)

Terminated
  • Thrombocytopenia
  • Bangbu, Anhui, China
  • +14 more
Feb 26, 2022

Immune Thrombocytopenia Trial in Beijing (Cyclosporine Oral Product, Prednisone)

Not yet recruiting
  • Immune Thrombocytopenia
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Jul 14, 2022

Thrombotic Thrombocytopenia Syndrome in Integrated Health-care

Recruiting
  • COVID-19
  • Pre-COVID-19
  • +2 more
  • Oxford, United Kingdom
    Research Site
Feb 2, 2023

Thrombocytopenia, Immune, Heparin Induced Thrombocytopenia Trial (VLX-1005, Placebo)

Not yet recruiting
  • Thrombocytopenia, Immune
  • Heparin Induced Thrombocytopenia
  • (no location specified)
Mar 24, 2023

Purpura, Thrombocytopenic, Idiopathic Trial in Beijing (all-trans retinoic acid, Eltrombopag)

Not yet recruiting
  • Purpura, Thrombocytopenic, Idiopathic
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Jun 25, 2022

Pneumonia, Thrombocytopenia Trial (recombinant human thrombopoietin, normal saline)

Not yet recruiting
  • Pneumonia
  • Thrombocytopenia
  • recombinant human thrombopoietin
  • normal saline
  • (no location specified)
Jan 19, 2022

Purpura, Thrombocytopenic, Idiopathic Trial in Germany, United Kingdom, United States (BIVV009 6.5 grams, BIVV009 7.5 grams)

Completed
  • Purpura, Thrombocytopenic, Idiopathic
  • BIVV009 6.5 grams
  • BIVV009 7.5 grams
  • Georgetown, District of Columbia
  • +4 more
Apr 22, 2022

Some Cytokines Expression in ITP Primary Immune Thrombocytopenic

Recruiting
  • Primary Immune Thrombocytopenia
  • Plasma RNA isolation, qPCR analysis of micro RNA
  • +2 more
  • Sohag, Egypt
    Sohag University
May 7, 2022

Immune Thrombocytopenia, Idiopathic Thrombocytopenic Purpura, Warm Autoimmune Hemolytic Anemia Trial (povetacicept)

Not yet recruiting
  • Immune Thrombocytopenia
  • +3 more
  • (no location specified)
Mar 9, 2023

Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Ipoh (NS-018,

Recruiting
  • Primary Myelofibrosis
  • +2 more
  • Worcester, Massachusetts
  • +16 more
Oct 31, 2022

MDS Trial (Hetrombopag)

Not yet recruiting
  • Myelodysplastic Syndromes
  • (no location specified)
May 23, 2022

Esophageal Cancer, Intensity-modulated Radiation Therapy, Concurrent Chemoradiotherapy Trial in Beijing (rhTPO)

Not yet recruiting
  • Esophageal Cancer
  • +3 more
  • Beijing, Beijing, China
    Department of Radiation Oncology, Cancer Institute and Hospital,
Jul 12, 2023

Genomics and COVID-19 Vaccine Adverse Events

Recruiting
  • Vaccine Adverse Reaction
  • COVID-19 vaccines
  • Vancouver, British Columbia, Canada
    British Columbia Children's Hospital Research Institute
Jun 24, 2022

Evaluate the Use and Effectiveness of Doptelet® in ITP

Recruiting
  • Immune Thrombocytopenia
  • ITP
  • Zagreb, Croatia
  • +59 more
Jan 12, 2023

Venous Thromboembolism Trial (Fondaparinux, Enoxaparin)

Terminated
  • Venous Thromboembolism
  • (no location specified)
Apr 7, 2022

Sepsis, Thrombocytopenia Trial in Shanghai (rhTPO, Placebo)

Recruiting
  • Sepsis
  • Thrombocytopenia
  • Shanghai, Shanghai, China
    Shanghai General Hospital, Shanghai Jiaotong University
Oct 25, 2022

Immune Thrombocytopenia Trial in Beijing (Zanubrutinib, Eltrombopag)

Not yet recruiting
  • Immune Thrombocytopenia
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
May 6, 2022